Adriaan van der Meer

ORCID: 0000-0002-9871-4022
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Liver Disease Diagnosis and Treatment
  • Liver Diseases and Immunity
  • Hepatitis C virus research
  • Gallbladder and Bile Duct Disorders
  • Pediatric Hepatobiliary Diseases and Treatments
  • Hepatitis B Virus Studies
  • Liver Disease and Transplantation
  • Hepatitis Viruses Studies and Epidemiology
  • Pancreatitis Pathology and Treatment
  • Drug Transport and Resistance Mechanisms
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Alkaline Phosphatase Research Studies
  • Race, Genetics, and Society
  • Organ Transplantation Techniques and Outcomes
  • Renal Transplantation Outcomes and Treatments
  • Antibiotics Pharmacokinetics and Efficacy
  • Pesticide Residue Analysis and Safety
  • Gastrointestinal Tumor Research and Treatment
  • Gastrointestinal Bleeding Diagnosis and Treatment
  • Sympathectomy and Hyperhidrosis Treatments
  • Complement system in diseases
  • Gastrointestinal disorders and treatments
  • Cancer Treatment and Pharmacology
  • Pituitary Gland Disorders and Treatments
  • Inflammatory Bowel Disease

Erasmus MC
2014-2025

European X-Ray Free-Electron Laser
2024

Erasmus University Rotterdam
2014-2023

European Foundation for the Study of Chronic Liver Failure
2021

Background & Aims Patients with autoimmune hepatitis (AIH) almost inevitably require lifelong immunosuppressive treatment. There is genuine concern about the efficacy and tolerability of current standard combination therapy prednisolone azathioprine. Mycophenolate mofetil (MMF) has emerged as an alternative option. The aim this study was to compare MMF azathioprine induction therapy. Methods In 24-week, prospective, randomised, open-label, multicentre superiority trial, 70 patients...

10.1016/j.jhep.2023.11.032 article EN cc-by Journal of Hepatology 2023-12-14

Summary Background Fibrosis stage predicts prognosis in patients with chronic liver disease independent of aetiology, although its precise role risk stratification primary biliary cholangitis (PBC) remains undefined. Aim To assess the utility baseline fibrosis predicting long‐term outcomes context biochemical Methods In a large and globally representative cohort PBC, biopsies performed from 1980 to 2014 were evaluated. The predictive ability histologic addition treatment response at 1 year...

10.1111/apt.15533 article EN Alimentary Pharmacology & Therapeutics 2019-10-17

Background and Aims: Normal alkaline phosphatase (ALP) levels in ursodeoxycholic acid (UDCA)-treated patients with primary biliary cholangitis (PBC) are associated better long-term outcome. However, second-line therapies currently recommended only when ALP remain above 1.5 times the upper limit of normal (×ULN) after 12-month UDCA. We assessed whether, considered good responders to UDCA, were significant survival gains. Approach Results: performed a retrospective cohort study 1047 PBC who...

10.1097/hep.0000000000000529 article EN Hepatology 2023-07-03
Francesca Colapietro Patrick Maisonneuve Ellina Lytvyak Ulrich Beuers Robert C. Verdonk and 95 more Adriaan van der Meer Bart van Hoek Sjoerd D. Kuiken Johannes T. Brouwer Paolo Muratori Alessio Aghemo F. Carella Ad P. van den Berg Kalliopi Zachou George Ν. Dalekos Daniel E. Di Zeo-Sánchez Mercedes Robles‐Díaz Raúl J. Andrade Aldo J. Montaño‐Loza Floris F. van den Brand Charlotte D. Slooter Guilherme Macedo Rodrigo Liberal Ynto S. de Boer Ana Lleò Nani Van Gerven Karel van Erpecum J. den Ouden Johannes T. Brouwer Jan Maarten Vrolijk Tom J.G. Gevers Joost P.H. Drenth Maureen M. J. Guichelaar Xiong Ma T.C.M.A. Schreuder E.J. van der Wouden Lubbertus C. Baak P. Stadhouders Michael Klemt‐Kropp M.A.M.T. Verhagen Anshul Bhalla J. Kuijvenhoven Piero Luigi Almasio Fernando Álvarez Raúl J. Andrade Çiğdem Arıkan David N. Assis Edouard Bardou‐Jacquet Maaike Biewenga Eduardo Luiz Rachid Cançado Nora Cazzagon Olivier Chazouillères Guido Colloredo Miriam Cuarterolo George Ν. Dalekos Dominique Debray Mercedes Robles‐Díaz Joost P.H. Drenth Jessica Dyson Cumali Efe Bastian Engel S. Ferri R Fontana Nikolaos Gatselis Alessio Gerussi Emina Halilbasic Neil Halliday Michael A. Heneghan Gideon M. Hirschfield Bart van Hoek Marianne Hørby Jørgensen G. Indolfini Raffaele Iorio Pietro Invernizzi Soo Jeong David Jones Déirdre Kelly Nanda Kerkar Florence Lacaille Craig Lammert B. Leggett Marco Lenzi C. Levy Rodrigo Liberal Ana Lleò Ansgar W. Lohse Susana López Eléonora De Martin Valérie A. McLin Giorgina Mieli‐Vergani Piotr Milkiewicz Nitesh Mohan Luigi Muratori Gabriella Nebbia C. van Nieuwkerk Ye Htun Oo Alberto Ortega Albert Parés Tudor Lucian Pop Daniel S. Pratt

10.1016/j.jhep.2023.09.010 article EN Journal of Hepatology 2023-10-05

Abstract Background Autoimmune hepatitis (AIH) is a rare, chronic inflammatory disease of the liver. The treatment goal reaching complete biochemical response (CR), defined as normalisation aspartate and alanine aminotransferases immunoglobulin gamma. Ongoing AIH activity can lead to fibrosis (decompensated) cirrhosis. Incomplete most important risk factor for liver transplantation or liver-related mortality. First-line consists combination azathioprine prednisolone. If CR not reached,...

10.1186/s13063-023-07832-w article EN cc-by Trials 2024-01-17

Abstract Background Inflammatory bowel disease (IBD) in patients with primary sclerosing cholangitis (PSC) is a distinct entity requiring specific management1. Data on characterisation of the phenotype PSC-IBD are limited and subclassification lacking. Therefore, this study aims to describe macroscopic microscopic distribution IBD PSC. Methods A retrospective analysis was conducted data from included EpiPSC2 registry, comprising 46 hospitals across Netherlands. inflammation at macro- level...

10.1093/ecco-jcc/jjae190.1396 article EN Journal of Crohn s and Colitis 2025-01-01

The main cholestatic liver diseases comprise primary sclerosing cholangitis (PSC), biliary (PBC), and IgG4-related (IgG4-C). Despite being classified as rare these are becoming gradually more important in the field of hepatology since their incidence is slowly rising while viral hepatitis burden declining. Cholestatic now rank among three most frequent indications for transplantation many Western countries. An accurate understanding epidemiology disease on both individual society great...

10.1097/hep.0000000000001341 article EN Hepatology 2025-04-01

Abstract Background and Aims Adenosine triphosphate‐binding cassette subfamily B member 4 (ABCB4) deficiency may lead to progressive familial intrahepatic cholestasis type 3 (PFIC3), biliary cirrhosis, low phospholipid‐associated cholelithiasis (LPAC), of pregnancy (ICP), oral contraceptive‐induced (CIC) or remain asymptomatic. The long‐term course, quality life histology were investigated in ABCB4 deficiency. Methods Adult carriers gene variants from two regional academic centres analysed...

10.1111/liv.14662 article EN Liver International 2020-09-27

Clinical practice guidelines support caregivers to manage liver diseases. However, people with lifelong conditions often lack guidance understand what aspects of care are most important and how their disease should be managed. This study aimed create a question prompt list (QPL) for individuals primary biliary cholangitis (PBC) including key questions (directed) treating physician which likely improve outcome. International PBC-professionals patient representatives rated ranked related 9 PBC...

10.1016/j.cgh.2025.01.037 article EN cc-by Clinical Gastroenterology and Hepatology 2025-04-01

Background & AimsBiochemical remission, important treatment goal in autoimmune hepatitis (AIH), has been associated with better long-term survival. The aim of this study was to determine the independent prognostic value aminotransferases and immunoglobulin G (IgG) during on transplant-free survival AIH.MethodsIn a multicenter cohort alanine aminotransferase, aspartate aminotransferase (AST), IgG were collected at diagnosis 6, 12, 24, 36 months after start therapy related outcome using...

10.1016/j.cgh.2021.05.024 article EN cc-by Clinical Gastroenterology and Hepatology 2021-05-19

The Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) pandemic has once more emphasized the urgent need for accurate and fast point-of-care (POC) diagnostics outbreak control prevention. main challenge in development of POC vitro (IVD) is to combine a short time result with high sensitivity, keep testing cost-effective. In this respect, sensors based on photonic integrated circuits (PICs) may offer advantages as they have features such analytical capability multiplexing, ease...

10.3390/bios12080553 article EN cc-by Biosensors 2022-07-22

10.1016/j.dld.2024.01.007 article EN Digestive and Liver Disease 2024-02-01
Maria C. van Hooff Adriaan J. van der Meer Vincent Karam René Adam Pavel Taimr and 95 more Wojciech G. Polak Hasina Pashtoun Sarwa Darwish Murad Christophe Corpechot Darius F. Mirza Michael A. Heneghan J. Peter A. Lodge Gabriel C. Oniscu Douglas Thorburn Michael Allison Herold J. Metselaar Caroline M. den Hoed Adriaan van der Meer Darius Mirza Michael A. Heneghan J. Peter A. Lodge Gabriel C. Oniscu Douglas Thorburn Michael Allison Johann Pratschke Manas Derek William Bennet Pål‐Dag Line Emir Hoti Krzysztof Zieniewicz B.-G. Ericzon Jiří Froněk Jürgen Klempnauer Allan Rasmussen Renato Romagnoli Petr Němec Arno Nordin A Paul Paola De Simone Robert J. Porte Gabriela Berlakovich Daniel Cherqui Jacques Pirenne Étienne Sokal G. Rossi Daniel Candinas Philippe Bachellier О. О. Руммо Karim Boudjéma Anna Mrzljak Olivier Soubrane Herold J. Metselaar Stefan Schneeberger Françis Navarro Thierry Berney Christophe Duvoux M. Colledan Luciano De Carlis Olivier Boillot Jean Hardwigsen F.R. Pruvot Bertrand Suc Marco Vivarelli Pierre A. Clavien Hauke Lang Maciej Kosieradzki Frederik Berrevoet Bruno Heyd Matteo Cescon L. Chiche E. Kochs Umberto Baccarani Olivier Detry Michael Bartels Massimo Rossi Olivier Soubrane Olivier Scatton Vasileios Papanikolaou Ian P.J. Alwayn Peter Schemmer N. Senninger Christian Ducerf Fabrizio Di Benedetto Giuseppe Tisone Silvio Nadalin Zoltán Máthé Marija Ribnikar Utz Settmacher Thomas Becker Nuno A. Silva Jorge Daniel Irinel Popescu Valério Lucidi Wolf O. Bechstein Thomas Decaens Jean Gugenheim Salvatore Gruttadauria Frausto Zamboni Murat Zeytunlu Jorg C. Kalff

BackgroundTacrolimus has been associated with recurrence of primary biliary cholangitis (PBC) after liver transplantation (LT), which in turn may reduce survival. This study aimed to assess the relation between type calcineurin inhibitor (CNI) and long-term outcomes following LT patients PBC.MethodsSurvival analyses were used association immunosuppressive drugs graft or patient survival among adult PBC dataset European Liver Transplant Registry. Patients who received a donation brain death...

10.1016/j.jhepr.2024.101100 article EN cc-by JHEP Reports 2024-04-25

Abstract Background Inflammatory bowel disease (IBD) is the strongest known risk factor for primary sclerosing cholangitis (PSC) and seems associated with a worse prognosis. After liver transplantation, colectomy decreased rates of recurrent PSC better graft survival.1 At same time, effect on course remains unclear.2 Available evidence depends either small patient numbers, may be confounded by unobserved factors or was not considered as time-depending covariate. The aim our study to estimate...

10.1093/ecco-jcc/jjac190.0010 article EN Journal of Crohn s and Colitis 2023-01-30
Coming Soon ...